After deliberating for more than a day, a federal jury in Arkansas has found for Wyeth Pharmaceuticals in the latest lawsuit claiming that the company's hormone replacement drugs cause breast cancer. Lawyers for Wyeth had said the plaintiff likely would have developed breast cancer regardless of whether she took Premarin and Prempro because of genetic and health factors, such as weight gain and a history of smoking. Since last fall, Wyeth has won two Prempro cases and lost one; another ended in a mistrial.
February 16, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A federal jury in Arkansas has ruled for Wyeth Pharmaceuticals in the latest lawsuit claiming that the company’s hormone replacement drugs cause breast cancer. After deliberating for more than a day, a jury in Little Rock sided with Wyeth in a case filed by Helene Rush of Little Rock.
In her lawsuit, Rush accused the drug maker of negligence in its hormone replacement therapy. More than 5,000 similar suits have been filed across the country.
Presented by BigVoodoo
Celebrating achievement, excellence, and innovation in the legal profession in the UK.
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
Role TitleAssociate General Counsel, Global EmploymentGrade F13Reporting ToSenior Legal Counsel, Global EmploymentProgram/Tool/ Department/U...
Ryan & Conlon, LLP, is a boutique firm specializing in insurance defense. We are a small eclectic practice with a busy and fast paced en...
INTELLECTUAL PROPERTY PROSECUTION PARALEGAL - NEW JERSEY OR NEW YORK OFFICESProminent mid-Atlantic law firm with multiple regional office lo...
